Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
Learn More
Cav3.2 Antibody - BSA Free, Novus Biologicals™

Rabbit Polyclonal Antibody
Supplier: Novus Biologicals NBP241303
Description
Cav3.2 Polyclonal specifically detects Cav3.2 in Human, Mouse, Rat samples. It is validated for Western Blot, ELISA, Immunohistochemistry, Immunohistochemistry-Paraffin, Immunofluorescence.Specifications
Cav3.2 | |
Polyclonal | |
Unconjugated | |
PBS with 0.02% Sodium Azide | |
CACNA1H | |
Antibody was raised against a 16 amino acid peptide near the center of human CACNA1H. The immunogen is located within amino acids 1010 - 1060 of CACNA1H. Amino Acid Squence: AEGDANRSDTDEDKTS | |
Affinity Purified | |
RUO | |
8912 | |
Human, Mouse, Rat | |
IgG |
Western Blot, ELISA, Immunohistochemistry, Immunocytochemistry, Immunofluorescence, Immunohistochemistry (Paraffin) | |
1 mg/mL | |
Western Blot 1 - 2 ug/ml, ELISA, Immunohistochemistry 5 ug/ml, Immunocytochemistry/Immunofluorescence 20 ug/mL, Immunohistochemistry-Paraffin 5 ug/ml | |
CACNA1HB, calcium channel, voltage-dependent, T type, alpha 1H subunit, calcium channel, voltage-dependent, T type, alpha 1Hb subunit, Cav3.2, ECA6, EIG6, FLJ90484, Low-voltage-activated calcium channel alpha1 3.2 subunit, low-voltage-activated calcium channel alpha13.2 subunit, voltage dependent t-type calcium channel alpha-1H subunit, voltage-dependent T-type calcium channel subunit alpha-1H, voltage-gated calcium channel alpha subunit Cav3.2, voltage-gated calcium channel alpha subunit CavT.2, Voltage-gated calcium channel subunit alpha Cav3.2 | |
Rabbit | |
260 kDa | |
0.1 mg | |
Primary | |
Multiple isoforms of CACNA1H are known to exist. | |
Store at 4C short term. Aliquot and store at -20C long term. Avoid freeze-thaw cycles. |
Product Content Correction
Your input is important to us. Please complete this form to provide feedback related to the content on this product.
Product Title
Spot an opportunity for improvement?Share a Content Correction